A detailed history of Northern Trust Corp transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Northern Trust Corp holds 5,339,382 shares of EW stock, worth $362 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
5,339,382
Previous 5,716,261 6.59%
Holding current value
$362 Million
Previous $528 Million 33.27%
% of portfolio
0.06%
Previous 0.09%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$59.7 - $93.78 $22.5 Million - $35.3 Million
-376,879 Reduced 6.59%
5,339,382 $352 Million
Q2 2024

Aug 14, 2024

SELL
$84.3 - $94.31 $4.14 Million - $4.63 Million
-49,100 Reduced 0.85%
5,716,261 $528 Million
Q1 2024

May 14, 2024

SELL
$72.54 - $95.56 $13.6 Million - $17.9 Million
-186,889 Reduced 3.14%
5,765,361 $551 Million
Q4 2023

Feb 13, 2024

SELL
$61.71 - $77.76 $25 Million - $31.5 Million
-405,223 Reduced 6.37%
5,952,250 $454 Million
Q3 2023

Nov 13, 2023

BUY
$69.28 - $93.38 $16.7 Million - $22.5 Million
241,347 Added 3.95%
6,357,473 $440 Million
Q2 2023

Aug 11, 2023

SELL
$81.41 - $94.33 $35.4 Million - $41 Million
-434,642 Reduced 6.63%
6,116,126 $577 Million
Q1 2023

May 15, 2023

BUY
$74.26 - $84.51 $1.22 Million - $1.39 Million
16,469 Added 0.25%
6,550,768 $542 Million
Q4 2022

Feb 13, 2023

BUY
$68.3 - $87.44 $2.37 Million - $3.03 Million
34,664 Added 0.53%
6,534,299 $488 Million
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $7.36 Million - $9.59 Million
-89,395 Reduced 1.36%
6,499,635 $537 Million
Q2 2022

Aug 12, 2022

SELL
$86.5 - $128.27 $13.2 Million - $19.6 Million
-152,687 Reduced 2.26%
6,589,030 $627 Million
Q1 2022

May 13, 2022

SELL
$101.96 - $128.34 $3.79 Million - $4.78 Million
-37,218 Reduced 0.55%
6,741,717 $794 Million
Q4 2021

Feb 08, 2022

BUY
$106.37 - $130.68 $1.28 Million - $1.57 Million
12,042 Added 0.18%
6,778,935 $878 Million
Q3 2021

Nov 15, 2021

BUY
$102.91 - $122.75 $7.81 Million - $9.31 Million
75,851 Added 1.13%
6,766,893 $766 Million
Q2 2021

Aug 13, 2021

SELL
$83.84 - $104.76 $8 Million - $10 Million
-95,426 Reduced 1.41%
6,691,042 $693 Million
Q1 2021

May 12, 2021

SELL
$78.68 - $90.67 $143,197 - $165,019
-1,820 Reduced 0.03%
6,786,468 $568 Million
Q4 2020

Feb 11, 2021

SELL
$71.69 - $91.23 $19.4 Million - $24.6 Million
-270,042 Reduced 3.83%
6,788,288 $619 Million
Q3 2020

Nov 16, 2020

SELL
$67.19 - $87.44 $4.1 Million - $5.33 Million
-60,991 Reduced 0.86%
7,058,330 $563 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $275 Million - $368 Million
4,776,572 Added 203.89%
7,119,321 $492 Million
Q1 2020

May 14, 2020

SELL
$52.41 - $81.0 $1.32 Million - $2.04 Million
-25,134 Reduced 1.06%
2,342,749 $442 Million
Q4 2019

Feb 14, 2020

SELL
$71.7 - $82.09 $824,550 - $944,035
-11,500 Reduced 0.48%
2,367,883 $552 Million
Q3 2019

Nov 13, 2019

SELL
$61.55 - $75.43 $2.66 Million - $3.26 Million
-43,216 Reduced 1.78%
2,379,383 $523 Million
Q2 2019

Aug 13, 2019

BUY
$55.74 - $64.41 $2.73 Million - $3.15 Million
48,931 Added 2.06%
2,422,599 $448 Million
Q1 2019

May 13, 2019

BUY
$47.89 - $64.05 $1.08 Million - $1.44 Million
22,536 Added 0.96%
2,373,668 $454 Million
Q4 2018

Feb 12, 2019

BUY
$46.41 - $56.94 $3.5 Million - $4.29 Million
75,391 Added 3.31%
2,351,132 $360 Million
Q3 2018

Nov 14, 2018

SELL
$45.7 - $58.03 $4.88 Million - $6.2 Million
-106,847 Reduced 4.48%
2,275,741 $396 Million
Q2 2018

Sep 18, 2018

SELL
$42.45 - $51.3 $570,867 - $689,882
-13,448 Reduced 0.56%
2,382,588 $347 Million
Q2 2018

Aug 14, 2018

BUY
$42.45 - $51.3 $595,106 - $719,174
14,019 Added 0.59%
2,396,036 $349 Million
Q1 2018

May 09, 2018

SELL
$37.19 - $47.45 $1.43 Million - $1.82 Million
-38,356 Reduced 1.58%
2,382,017 $332 Million
Q4 2017

Feb 14, 2018

SELL
$33.79 - $39.39 $1.11 Million - $1.29 Million
-32,770 Reduced 1.34%
2,420,373 $273 Million
Q3 2017

Nov 13, 2017

BUY
$36.29 - $38.83 $89 Million - $95.3 Million
2,453,143
2,453,143 $268 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.